IR@PKUHSC  > 北京大学临床肿瘤学院  > 肿瘤内科
学科主题临床医学
A randomized, double-blind, placebo-controlled, multicenter Phase II clinical trial of fruquintinib in patients with metastatic colorectal cancer (mCRC)
Li, J.1; Xu, R.2; Bai, Y.3; Xu, J.4; Liu, T.5; Shen, L.6; Wang, L.7; Pan, H.8; Fan, S.9; Hua, Y.10; Su, W.11; Hugg, C.12
刊名EUROPEAN JOURNAL OF CANCER
2015-09-01
suppl.3页:S366-S366
收录类别SCI ; ISTP
文章类型Meeting Abstract
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
语种英语
WOS记录号WOS:000361887401458
引用统计
被引频次:1[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/54126
专题北京大学临床肿瘤学院_肿瘤内科
作者单位1.Fudan Univ, Shanghai Canc Ctr, Shanghai Med Coll, Dept Med Oncol, Shanghai 200433, Peoples R China
2.Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China
3.Harbin Med Univ, Canc Hosp, Dept Med Oncol, Harbin, Heilongjiang, Peoples R China
4.Chinese PLA, Hosp 307, Affiliated Hosp Mil Med Sci, Dept Med Oncol, Beijing, Peoples R China
5.Fudan Univ, Zhongshan Hosp, Shanghai Med Coll, Dept Med Oncol, Shanghai 200433, Peoples R China
6.Beijing Univ, Ctr Canc, Dept Med Oncol, Beijing 100871, Peoples R China
7.Shanghai Jiao Tong Univ, Affiliated People Hosp 1, Dept Med Oncol, Shanghai 200030, Peoples R China
8.Hutchison MediPharma Ltd, Res, Shanghai, Peoples R China
9.Hutchison MediPharma Ltd, Corp Off, Shanghai, Peoples R China
10.Zhejiang Univ, Coll Med, SIR RUN RUN SHAW Hosp, Dept Med Oncol, Hangzhou 310003, Zhejiang, Peoples R China
11.Hutchison MediParma Ltd, Clin & Regulatory Affair, Shanghai, Peoples R China
12.Hutchison MediPharma Ltd, Clin & Regulatory Affair, Shanghai, Peoples R China
推荐引用方式
GB/T 7714
Li, J.,Xu, R.,Bai, Y.,et al. A randomized, double-blind, placebo-controlled, multicenter Phase II clinical trial of fruquintinib in patients with metastatic colorectal cancer (mCRC)[J]. EUROPEAN JOURNAL OF CANCER,2015,suppl.3:S366-S366.
APA Li, J..,Xu, R..,Bai, Y..,Xu, J..,Liu, T..,...&Hugg, C..(2015).A randomized, double-blind, placebo-controlled, multicenter Phase II clinical trial of fruquintinib in patients with metastatic colorectal cancer (mCRC).EUROPEAN JOURNAL OF CANCER,suppl.3,S366-S366.
MLA Li, J.,et al."A randomized, double-blind, placebo-controlled, multicenter Phase II clinical trial of fruquintinib in patients with metastatic colorectal cancer (mCRC)".EUROPEAN JOURNAL OF CANCER suppl.3(2015):S366-S366.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Li, J.]的文章
[Xu, R.]的文章
[Bai, Y.]的文章
百度学术
百度学术中相似的文章
[Li, J.]的文章
[Xu, R.]的文章
[Bai, Y.]的文章
必应学术
必应学术中相似的文章
[Li, J.]的文章
[Xu, R.]的文章
[Bai, Y.]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。